B

Braxia Scientific
BRAX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CA$1.42M
EV
CA$1.92M
Shares Outstanding
283.28M
Beta
1.38
Industry
Biotechnology

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2024E
-
P/Revenue 2024E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Braxia Scientific Corp.

gainify

B

Braxia Scientific Corp.

BRAX

Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorder...

Sector

Healthcare

Industry

Biotechnology

CEO

McIntyre, Roger

Employees

IPO Date

2020-03-02

Headquarters

700 Bay Street, Suite 1903, Toronto, Ontario, M5G 1Z6, Canada

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.